共 50 条
- [4] Will inter partes review speed US generic drug entry? [J]. NATURE BIOTECHNOLOGY, 2017, 35 (12) : 1139 - 1141
- [5] Will inter partes review speed US generic drug entry? [J]. Nature Biotechnology, 2017, 35 : 1139 - 1141
- [6] New Drug Formulations and Their Respective Generic Entry Dates [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (02): : 218 - 224
- [7] Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity [J]. Review of Industrial Organization, 2018, 53 : 139 - 172